R&D Consortium to Develop Optical Sorting of Stem Cells
News Dec 17, 2013
Danish project partners OptoRobotix (R&D performing SME) and Bioneer (technological service partner) and Dolomite will jointly develop a cutting edge stem cell handling technology. As the market leader in microfluidic design, Dolomite will exploit its latest offerings to transform from concept to biotech device. The collaboration recognizes Dolomite’s proven track of Productizing Science®, its unique business philosophy.
Named OPTISORT (E! 7790 OPTISORT), the platform is expected to provide ‘Sorting and analysis platform for fragile mammalian cells using novel combination of optical and droplet technology’. The areas of stem cell biology and mammalian cell based protein manufacturing are developing fast. The ability for gentle cell sorting technologies and methods is expected to enable customers exploit unprecedented applications of cell biology in technology. The Consortium combines novel optical and droplet technology to create a commercial attractive platform. The collaboration has awarded close to 1 million Euros with a view to benefit the biotechnology, pharmaceutical and molecular biology industry.
The collaboration is made possible by the Eurostars Programme – a European Joint Programme dedicated to the R&D performing SMEs, co-funded by the European Communities and 33 EUREKA member countries. Eurostars aims to stimulate SMEs with a promising potential for international collaborative research and innovation, enabling the route to international markets. Eurostars, the first European funding programme dedicated to innovation driven SMEs highlights their importance as essential sources of growth, employment, entrepreneurial skills, innovation and economic and social cohesion. On average, a Eurostars project has 3 to 4 Participants, 2-3 Countries, 29 Months duration, and €1.4M R&D budget. Of a total of 9807 applicants, 613 Projects were successfully funded with a total budget of €878M (€390M Estimated Public Funding).
Miniature Testing of Drug Pairs on Tumor BiopsiesNews
Combinations of cancer drugs can be quickly and cheaply tested on tumour cells using a novel device. The research marks the latest advancement in the field of personalised medicine. Using a microfluidic device that fits in the palm of your hand, scientists screened over 1100 treatment conditions on patient tumour cells. In the future, such tests could be used to inform clinicians on safe and effective combinations of cancer treatments.READ MORE
Watching Stem Cells Repair Spinal Cord in Real TimeNews
Clues to the reversal of brain and spine injury.READ MORE